Immutep Limited
PRRUF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | $421 | $469 | $334 | $422 |
| - Cash | $67 | $74 | $162 | $104 |
| + Debt | $2 | $2 | $2 | $2 |
| Enterprise Value | $355 | $397 | $173 | $319 |
| Revenue | $1 | $3 | $2 | $2 |
| % Growth | -69.9% | 81.8% | -18% | – |
| Gross Profit | -$17 | -$22 | -$19 | $1 |
| % Margin | -1,802.8% | -704.7% | -1,119.4% | 52.8% |
| EBITDA | -$18 | -$26 | -$22 | -$22 |
| % Margin | -1,924.1% | -838.5% | -1,290.8% | -1,051.7% |
| Net Income | -$20 | -$22 | -$21 | -$21 |
| % Margin | -2,059.8% | -710.9% | -1,241.3% | -1,005.7% |
| EPS Diluted | -0.013 | -0.015 | -0.018 | -0.018 |
| % Growth | 13% | 13% | 0% | – |
| Operating Cash Flow | -$17 | -$20 | -$7 | -$9 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$17 | -$20 | -$8 | -$9 |